Outcome of kidney transplantation from high-risk donors is determined by both structure and function
- PMID: 10232568
- DOI: 10.1097/00007890-199904270-00013
Outcome of kidney transplantation from high-risk donors is determined by both structure and function
Abstract
Method: Despite the need to expand the donor pool, it is unclear what parameters should be used. The value of donor renal pathology and calculated creatinine clearance (CrCl) in determining recipient outcome was assessed in 57 kidney transplants from 34 donors in whom pretransplant renal biopsies were performed because of age > or =60, hypertension, and/or vascular disease. We retrospectively compared clinical outcomes in these recipients and 57 control recipients selected to have the same baseline demographics but receiving transplants from low risk donors who were significantly younger (32+/-13.9 vs. 61+/-7.3 years) and lighter weight (71+/-18.1 vs. 84+/-20.2 kg) than the high-risk donors (P<.001 for both).
Results: Recipients of high-risk kidneys had a higher incidence of delayed graft function, defined by a <10% fall in serum creatinine (Cr) in the first 24 hr, (56% vs. 30%, P<.01), a higher incidence of rejection (60% vs. 37%, P = .02) and a higher Cr level (197+/-64 vs. 144+/-54 micromol/L at 18 months, P<.005). Graft and patient survival were similar; 12% and 5% vs. 91% and 9% in high-risk vs. control groups, respectively (P = NS). Donor renal pathology was scored 0-3 (none to severe disease) in four areas: glomerulosclerosis, interstitial fibrosis, tubular atrophy, and vascular disease. A donor vessel score of 3/3 was associated with a 100% incidence of delayed graft function and a mean 1-year Cr level of 275+106 micromol/L (compared with 43% and 192+54 micromol/L in those with lower vessel scores, P<.05). Calculated donor CrCl <100 ml/min was associated with higher recipient Cr levels at 1 year, 240+/-95 micromol/L vs. 180+/-54 micromol/L in recipients of kidneys from donors with CrCl levels >100 ml/min (P<.05). The mean 1-year Cr level was 320+/-102 micromol/L in recipients with both a vascular score of 3/3 and a donor CrCl <100 ml/min and 184+/-63 micromol/L in those with neither factor (P = .001).
Conclusion: Calculated donor CrCl and donor vascular pathology predict recipient graft function and may be helpful in selecting high-risk donors for single kidney transplantation.
Similar articles
-
Histopathology and Long-Term Outcome of Kidneys Transplanted From Donors With Severe Acute Kidney Injury.Prog Transplant. 2019 Mar;29(1):36-42. doi: 10.1177/1526924818817054. Epub 2018 Dec 13. Prog Transplant. 2019. PMID: 30832558
-
When should expanded criteria donor kidneys be used for single versus dual kidney transplants?Transplantation. 1997 Oct 27;64(8):1142-6. doi: 10.1097/00007890-199710270-00011. Transplantation. 1997. PMID: 9355831
-
Dual kidney transplantation: older donors for older recipients.J Am Coll Surg. 1999 Jul;189(1):82-91; discussion 91-2. doi: 10.1016/s1072-7515(99)00073-3. J Am Coll Surg. 1999. PMID: 10401744
-
Variables during care of adult donors that can influence outcomes of kidney transplantation.Prog Transplant. 2005 Sep;15(3):219-24; quiz 225. doi: 10.1177/152692480501500304. Prog Transplant. 2005. PMID: 16252627 Review.
-
Systematic review of kidney transplantation functional predictors.Actas Urol Esp (Engl Ed). 2018 May;42(4):218-226. doi: 10.1016/j.acuro.2017.07.004. Epub 2017 Aug 10. Actas Urol Esp (Engl Ed). 2018. PMID: 28803679 English, Spanish.
Cited by
-
Assessment of kidney organ quality and prediction of outcome at time of transplantation.Semin Immunopathol. 2011 Mar;33(2):185-99. doi: 10.1007/s00281-011-0248-x. Epub 2011 Jan 28. Semin Immunopathol. 2011. PMID: 21274534 Review.
-
Value of original and modified pathological scoring systems for prognostic prediction in paraffin-embedded donor kidney core biopsy.Ren Fail. 2024 Dec;46(1):2314630. doi: 10.1080/0886022X.2024.2314630. Epub 2024 Feb 12. Ren Fail. 2024. PMID: 38345067 Free PMC article.
-
[Pulse pressure variation guided fluid therapy during kidney transplantation: a randomized controlled trial].Braz J Anesthesiol. 2020 May-Jun;70(3):194-201. doi: 10.1016/j.bjan.2020.02.008. Epub 2020 May 12. Braz J Anesthesiol. 2020. PMID: 32534731 Free PMC article. Clinical Trial.
-
Renal Transplantation from a Deceased Donor with Polycystic Kidney Disease.Case Rep Transplant. 2021 Aug 16;2021:6711155. doi: 10.1155/2021/6711155. eCollection 2021. Case Rep Transplant. 2021. PMID: 34447598 Free PMC article.
-
Effects of polyunsaturated fatty acids (PUFAs) in the treatment of experimental chronic renal failure.Int Urol Nephrol. 2012 Oct;44(5):1571-6. doi: 10.1007/s11255-012-0227-8. Epub 2012 Jul 1. Int Urol Nephrol. 2012. PMID: 22752498
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous